Medifast (MED) Stock Rally Leans On Cash As Coach Base Shrinks
Medifast's stock rallied 34% despite Q2 2026 losses and shrinking revenue, with investors focusing on the company's strong cash position and debt-free balance sheet. Management plans a 10-year metabolic health pivot, aiming to leverage its US$170 million in cash to transition from a declining …